ADAR1 Capital Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

ADAR1 Capital Management’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-816,581	Closed	-$1.3M	–	328
2024 Q1	$1.3M	Buy	+816,581	New	+$1.21M	0.29%	55

ADAR1 Capital Management's NGM Position: Q2 2024 in Review

ADAR1 Capital Management sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 816,581 shares — an estimated $1.3M sold.

ADAR1 Capital Management first reported a position in NGM in Q1 2024 and held it in 1 quarter. The position peaked at $1.3M in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

ADAR1 Capital Management reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
ADAR1 Capital Management sold 816,581 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.3M.
ADAR1 Capital Management first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
ADAR1 Capital Management's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $1.3M in Q1 2024.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on ADAR1 Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.